Clinical Trials Logo
  1. Home
  2. Cyclic Vomiting Syndrome
  3. NCT05065567

Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis

Cyclic Vomiting Syndrome Clinical Trial

Official title:
A Comparison of Haloperidol 5mg IM vs Droperidol 2.5mg and Ondansetron for the Treatment of Hyperemesis in Cannabis Hyperemesis Syndrome

Clinical Trial Summary

The purpose of this study is to compare two commonly used agents for the treatment of cyclic vomiting to see if one agent is inferior to the other in time to improvement in symptoms, need for repeat or rescue medications, treatment failures and complications/side effects.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05065567
Study type Interventional
Source Spectrum Health - Lakeland
Contact
Status Terminated
Phase Phase 2
Start date August 30, 2021
Completion date November 20, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT04329637 - Effects of an Integrative Health Care Model With Meditation and Care Cordination in CVS N/A
Withdrawn NCT00728104 - The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS) N/A
Recruiting NCT05256160 - Cortical Excitability in Cyclic Vomiting Syndrome N/A
Recruiting NCT05961995 - Heartfulness Meditation Cyclic Vomiting Syndrome N/A
Completed NCT03434652 - Auricular Neurostimulation for Cyclic Vomiting Syndrome N/A
Completed NCT04645953 - Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome Phase 2
Completed NCT03470181 - Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
Completed NCT03295760 - Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children N/A
Terminated NCT04721171 - Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome. N/A